Ailex Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AILEX PHARMS LLC
AILEX PHARMS LLC has four approved drugs.
Summary for Ailex Pharms Llc
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Ailex Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ailex Pharms Llc | CROMOLYN SODIUM | cromolyn sodium | SOLUTION;INHALATION | 209453-001 | Oct 16, 2017 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ailex Pharms Llc | BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE | bismuth subsalicylate; metronidazole; tetracycline hydrochloride | TABLET, CHEWABLE, TABLET, CAPSULE;ORAL | 202584-001 | Nov 30, 2018 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Ailex Pharms Llc | SODIUM PHENYLACETATE AND SODIUM BENZOATE | sodium benzoate; sodium phenylacetate | SOLUTION;INTRAVENOUS | 207096-001 | Feb 24, 2016 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ailex Pharms Llc | CROMOLYN SODIUM | cromolyn sodium | CONCENTRATE;ORAL | 209264-001 | Oct 16, 2017 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
